Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: GSK executive lowers stake

Tue, 12th Feb 2019 15:31

(Sharecast News) - GlaxoSmithKline company Victoria Whyte disposed of 5,199 ordinary shares in the UK's biggest drugs company on Tuesday.Whyte, who joined GSK's corporate secretariat more than 30 years ago, sold the shares at an average price of 1,553.80p each, for a total transaction value of £80,782.06.Just last week, GlaxoSmithKline reported full-year sales of more than £30bn last Wednesday but warned that earnings in the current year would be hurt by generic competition to its blockbuster asthma treatment.GSK revealed 2018 group sales were £30.8bn, for a 2% increase on the previous year, while pre-tax profits were ahead by 36% at £4.8bn.Fourth-quarter sales came in at £8.2bn and adjusted earnings per share at 31.2p. Analysts had been looking for adjusted EPS of around 27.7p.As of 1630 GMT, GSK shares had picked up 0.40% to 1,551.80p.Top Director BuysGb Group (GBG)Director name: Rasche,David AAmount purchased: 48,780 @ 410.00pValue: £199,998.00Gb Group (GBG)Director name: Clark,ChrisAmount purchased: 39,024 @ 410.00pValue: £159,998.40Gb Group (GBG)Director name: Wilson ,David John Amount purchased: 37,972 @ 410.00pValue: £155,685.20Gb Group (GBG)Director name: Brown,NickAmount purchased: 37,971 @ 410.00pValue: £155,681.10Gb Group (GBG)Director name: Catchpole ,Liz Amount purchased: 12,195 @ 410.00pValue: £49,999.50Gb Group (GBG)Director name: Eggberry ,Charmaine Amount purchased: 9,756 @ 410.00pValue: £39,999.60Cranswick (CWK)Director name: Smith,TimAmount purchased: 1,500 @ 2,585.00pValue: £38,775.00Baillie Gifford Shin Nippon (BGS)Director name: Donaldson,Michael NeilAmount purchased: 859 @ 173.75pValue: £1,492.51F&c Investment Trust (FCIT)Director name: Bone,RogerAmount purchased: 147 @ 675.79pValue: £993.41Blackrock Throgmorton Trust (THRG)Director name: Beart,SimonAmount purchased: 149 @ 497.00pValue: £740.53Blackrock Throgmorton Trust (THRG)Director name: Beart,SimonAmount purchased: 149 @ 497.00pValue: £740.53F&c Investment Trust (FCIT)Director name: Hewitt,JeffreyAmount purchased: 74 @ 675.79pValue: £500.08Qinetiq Group (QQ.)Director name: Smith,DavidAmount purchased: 66 @ 306.32pValue: £202.17Qinetiq Group (QQ.)Director name: Wadey ,Steve Amount purchased: 65 @ 306.32pValue: £199.11United Utilities Group (UU.)Director name: Houlden,RussAmount purchased: 23 @ 824.37pValue: £189.61United Utilities Group (UU.)Director name: Mogford,Steven LAmount purchased: 22 @ 824.37pValue: £181.36Jpmorgan Japan Smaller Companies Trust (JPS)Director name: Henderson,AlexaAmount purchased: 50 @ 361.20pValue: £180.60United Utilities Group (UU.)Director name: Fraser,StevenAmount purchased: 21 @ 824.37pValue: £173.12Easyjet (EZJ)Director name: Findlay ,Andrew Amount purchased: 12 @ 1,290.00pValue: £154.80Arden Partners (ARDN)Director name: Clive Reed-Daunter,James (Jim)Amount purchased: 555 @ 27.00pValue: £149.85Arden Partners (ARDN)Director name: Brown,Donald Amount purchased: 555 @ 27.00pValue: £149.85Cobham (COB)Director name: Mellors,DavidAmount purchased: 132 @ 113.20pValue: £149.42Cobham (COB)Director name: Lockwood,DavidAmount purchased: 132 @ 113.20pValue: £149.42Oxford Instruments (OXIG)Director name: Barkshire,Ian Amount purchased: 15 @ 955.00pValue: £143.25Oxford Instruments (OXIG)Director name: Hill,GavinAmount purchased: 15 @ 955.00pValue: £143.25Glaxosmithkline (GSK)Director name: Redfern,David Amount purchased: 8 @ 1,554.33pValue: £124.35Glaxosmithkline (GSK)Director name: Walmsley,EmmaAmount purchased: 8 @ 1,554.33pValue: £124.35Glaxosmithkline (GSK)Director name: Whyte,VictoriaAmount purchased: 8 @ 1,554.33pValue: £124.35Glaxosmithkline (GSK)Director name: Dingemans,SimonAmount purchased: 8 @ 1,554.33pValue: £124.35F&c Investment Trust (FCIT)Director name: Knapp,EdwardAmount purchased: 15 @ 675.79pValue: £101.37Cobham (COB)Director name: Colloff,Lyn Amount purchased: 89 @ 113.20pValue: £100.75Top Director SellsStenprop Limited (STP)Director name: Carey,Julian Amount sold: 105,000 @ 112.13pValue: £117,731.25Glaxosmithkline (GSK)Director name: Whyte,VictoriaAmount sold: 5,199 @ 1,553.80pValue: £80,782.06
More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.